Harwood H J, Bridge D M, Stacpoole P W
J Clin Invest. 1987 Apr;79(4):1125-32. doi: 10.1172/JCI112928.
In vivo regulation of microsomal HMG CoA reductase activity was investigated in freshly isolated mononuclear leukocytes from 26 healthy adult males. Reductase activity exhibited a diurnal rhythm and decreased during fasting. Enzyme activity was also modulated in vivo by alterations in dietary and plasma cholesterol, suggesting the existence of an operative cholesterol feedback regulatory system. A single, high cholesterol meal decreased reductase activity within 2 h. In addition, rapid depletion of circulating cholesterol levels by plasmapheresis led to an approximately twofold elevation in enzyme activity within 90 min of treatment. Finally, reductase activity was inhibited by dichloroacetate, a compound known to lower plasma cholesterol in man and inhibit the human leukocyte enzyme in vitro. The regulatory mechanisms controlling HMG CoA reductase activity in the human mononuclear leukocyte in vivo thus are similar to those that modulate the mammalian liver enzyme in vivo. Assessment of mononuclear leukocyte reductase activity may provide insight into the in vivo regulation of human cholesterol metabolism.
在来自26名健康成年男性的新鲜分离的单核白细胞中,研究了微粒体HMG CoA还原酶活性的体内调节。还原酶活性呈现昼夜节律,且在禁食期间降低。酶活性也可通过饮食和血浆胆固醇的改变在体内进行调节,这表明存在一个有效的胆固醇反馈调节系统。一顿高胆固醇餐在2小时内可降低还原酶活性。此外,通过血浆置换快速降低循环胆固醇水平会导致治疗后90分钟内酶活性升高约两倍。最后,二氯乙酸可抑制还原酶活性,二氯乙酸是一种已知可降低人体血浆胆固醇并在体外抑制人白细胞酶的化合物。因此,体内控制人单核白细胞中HMG CoA还原酶活性的调节机制与体内调节哺乳动物肝脏酶的机制相似。评估单核白细胞还原酶活性可能有助于深入了解人体胆固醇代谢的体内调节。